Mondi plc (LON:MNDI)
London · Delayed Price · Currency is GBP · Price in GBp 1,079.00
+21.50 (2.03%)
Aug 8, 2025, 6:02 PM BST
Verve Therapeutics Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 7,586 | 7,416 | 7,330 | 8,902 | 6,974 | 6,663 | Upgrade | |
Revenue Growth (YoY) | 5.54% | 1.17% | -17.66% | 27.65% | 4.67% | -8.32% | Upgrade |
Cost of Revenue | 4,456 | 4,341 | 4,589 | 5,469 | 4,210 | 3,678 | Upgrade |
Gross Profit | 3,130 | 3,075 | 2,741 | 3,433 | 2,764 | 2,985 | Upgrade |
Selling, General & Admin | 1,727 | 1,662 | 1,469 | 1,429 | 1,358 | 1,403 | Upgrade |
Other Operating Expenses | 429 | 428 | 326 | 338 | 245 | 263 | Upgrade |
Operating Expenses | 2,625 | 2,533 | 2,203 | 2,172 | 1,978 | 2,094 | Upgrade |
Operating Income | 505 | 542 | 538 | 1,261 | 786 | 891 | Upgrade |
Interest Expense | -101 | -88 | -111 | -138 | -81 | -94 | Upgrade |
Interest & Investment Income | 17 | 30 | 45 | 6 | 5 | 5 | Upgrade |
Earnings From Equity Investments | -1 | -3 | -5 | 1 | 6 | -3 | Upgrade |
Currency Exchange Gain (Loss) | 1 | -3 | 1 | -5 | -2 | - | Upgrade |
EBT Excluding Unusual Items | 421 | 478 | 468 | 1,125 | 714 | 799 | Upgrade |
Merger & Restructuring Charges | -142 | -154 | -27 | - | 2 | -57 | Upgrade |
Gain (Loss) on Sale of Investments | 36 | 36 | 87 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 242 | - | - | Upgrade |
Asset Writedown | 7 | 7 | 125 | 169 | -6 | 27 | Upgrade |
Other Unusual Items | 4 | 8 | 2 | 17 | - | - | Upgrade |
Pretax Income | 329 | 378 | 682 | 1,560 | 712 | 770 | Upgrade |
Income Tax Expense | 99 | 116 | 161 | 301 | 152 | 168 | Upgrade |
Earnings From Continuing Operations | 230 | 262 | 521 | 1,259 | 560 | 602 | Upgrade |
Earnings From Discontinued Operations | - | - | -655 | 266 | 213 | - | Upgrade |
Net Income to Company | 230 | 262 | -134 | 1,525 | 773 | 602 | Upgrade |
Minority Interest in Earnings | -41 | -44 | -19 | -73 | -17 | -20 | Upgrade |
Net Income | 189 | 218 | -153 | 1,452 | 756 | 582 | Upgrade |
Net Income to Common | 189 | 218 | -153 | 1,452 | 756 | 582 | Upgrade |
Net Income Growth | - | - | - | 92.06% | 29.90% | -28.32% | Upgrade |
Shares Outstanding (Basic) | 441 | 444 | 441 | 441 | 441 | 441 | Upgrade |
Shares Outstanding (Diluted) | 441 | 444 | 441 | 441 | 441 | 441 | Upgrade |
Shares Change (YoY) | -0.73% | 0.70% | -0.02% | -0.02% | 0.08% | 0.06% | Upgrade |
EPS (Basic) | 0.43 | 0.49 | -0.35 | 3.29 | 1.71 | 1.32 | Upgrade |
EPS (Diluted) | 0.43 | 0.49 | -0.35 | 3.29 | 1.71 | 1.32 | Upgrade |
EPS Growth | - | - | - | 92.07% | 29.83% | -28.38% | Upgrade |
Free Cash Flow | -8 | -130 | 481 | 891 | 624 | 645 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.29 | 1.09 | 2.02 | 1.41 | 1.46 | Upgrade |
Dividend Per Share | 0.700 | 0.700 | 0.770 | 0.770 | 0.715 | 0.660 | Upgrade |
Dividend Growth | -6.25% | -9.09% | - | 7.69% | 8.33% | 5.21% | Upgrade |
Gross Margin | 41.26% | 41.46% | 37.39% | 38.56% | 39.63% | 44.80% | Upgrade |
Operating Margin | 6.66% | 7.31% | 7.34% | 14.16% | 11.27% | 13.37% | Upgrade |
Profit Margin | 2.49% | 2.94% | -2.09% | 16.31% | 10.84% | 8.73% | Upgrade |
Free Cash Flow Margin | -0.10% | -1.75% | 6.56% | 10.01% | 8.95% | 9.68% | Upgrade |
EBITDA | 943 | 954 | 920 | 1,630 | 1,139 | 1,296 | Upgrade |
EBITDA Margin | 12.43% | 12.86% | 12.55% | 18.31% | 16.33% | 19.45% | Upgrade |
D&A For EBITDA | 438 | 412 | 382 | 369 | 353 | 405 | Upgrade |
EBIT | 505 | 542 | 538 | 1,261 | 786 | 891 | Upgrade |
EBIT Margin | 6.66% | 7.31% | 7.34% | 14.16% | 11.27% | 13.37% | Upgrade |
Effective Tax Rate | 30.09% | 30.69% | 23.61% | 19.30% | 21.35% | 21.82% | Upgrade |
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.